Switch to:
Array BioPharma Inc (NAS:ARRY)
Cash And Cash Equivalents
$52.18 Mil (As of Mar. 2014)

Array BioPharma Inc's quarterly cash and cash equivalents increased from Sep. 2013 ($65.05 Mil) to Dec. 2013 ($120.37 Mil) but then declined from Dec. 2013 ($120.37 Mil) to Mar. 2014 ($52.18 Mil).

Array BioPharma Inc's annual cash and cash equivalents increased from Jun. 2011 ($48.10 Mil) to Jun. 2012 ($55.80 Mil) and increased from Jun. 2012 ($55.80 Mil) to Jun. 2013 ($60.74 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14
BS_CashAndCashEquivalents 12.4315.5710.6756.4533.2032.8548.1055.8060.74111.64

Array BioPharma Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
BS_CashAndCashEquivalents 63.0355.8049.0559.5744.0060.7465.05120.3752.18111.64
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK